Related references
Note: Only part of the references are listed.Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA
Jing Wang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant
Jae-Sook Ahn et al.
ANNALS OF HEMATOLOGY (2016)
Long-term follow-up of cytogenetically normal CEBPA-mutated AML
Friederike Pastore et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA
Richard F. Schlenk et al.
BLOOD (2013)
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
Bas J. Wouters et al.
BLOOD (2009)
Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'
H-A Hou et al.
BRITISH JOURNAL OF CANCER (2009)
Share Paper
